Please login to the form below

Not currently logged in
Email:
Password:

Adherence programme helps Janssen to PMEA success

Company picks up three awards including Company of the Year
Janssen Company of the Year PMEA 2013

An adherence programme to support treatment of people with mental health conditions helped spur Janssen to success at last night's Pharmaceutical Market Excellence Awards (PMEA) in London.

Janssen picked up the prestigious Accenture Award for PMEA Company of the Year at the event, which recognises responsible marketing and business practice in the pharma industry.

The Maintaining Adherence Programme, which was supported by Havas Lynx, claimed victory in the inVentiv Health Communications Award for Excellence in Healthcare Collaboration and Partnerships category and the KnowledgePoint360 Special Award for Innovation.

Commenting on Janssen's year, PMEA judges described the company as “an organisation driven by passion” which had a strong leader in the form of managing director Cesar Rodriguez.

Of special note was the company's approach to its employees and its success in market access in the UK.

“People enjoy working at Janssen - it was rated the top pharma company in The Sunday Times' Best Companies To Work For in 2012,” said the judges. “And the 100 per cent success rate Janssen have with NICE speaks for itself, a massive achievement in access for patients.”

Regarding the award-winning Maintaining Adherence Programme, judges praised Janssen's collaborative efforts with the South Essex Partnership University (SEPT) that used digital methods to improve medicines adherence for patients with schizophrenia, bipolar and affective disorders.

“Through a well-executed, multi-faceted, multi-channel, patient programme implemented alongside the NHS, Janssen used an innovative approach which improved adherence, reduced exacerbations and admissions and produced real outcomes for the community,” said the judges.

Run by PMLiVE's publisher the PMGroup, the PMEA programme is specifically designed to recognise and commend excellence, best practice and innovation in local, European and international healthcare markets.

Article by
Thomas Meek

28th November 2013

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....